A paradoxical pattern of indoleamine 2,3-dioxygenase expression in the colon tissues of patients with acute graft-versus-host disease

Experimental Hematology

Volumn 42, Issue 9, 2014, Pages 734-740

  Park, Gyeongsin ^a,b   Choi, Yeong Jin ^a   Lee, Sung Eun ^a   Lim, Ji Young ^a   Lee, Chulbom ^c   Choi, Eun Young ^d   Min, Chang Ki ^a  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c Seoul National University   (South Korea)

^d Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; INDOLEAMINE 2,3 DIOXYGENASE; STEROID; TACROLIMUS; INDOLEAMINE 2,3 DIOXYGENASE 1, HUMAN; INDOLEAMINE 2,3-DIOXYGENASE 1, HUMAN;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; COLON BIOPSY; COLON MUCOSA; CONTROLLED STUDY; DRUG RESPONSE; ENDOTHELIUM CELL; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN CELL; HUMAN TISSUE; LOW RISK PATIENT; MALE; MONONUCLEAR CELL; MORTALITY; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REDUCED INTENSITY CONDITIONING; REFRACTORY ANEMIA; RETROSPECTIVE STUDY; UPREGULATION; ACUTE DISEASE; ALLOGRAFT; BIOSYNTHESIS; COLON; DISEASE FREE SURVIVAL; ENZYMOLOGY; FOLLOW UP; GENE EXPRESSION REGULATION; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; INTESTINE MUCOSA; MIDDLE AGED; PATHOLOGY; SURVIVAL RATE;

ACUTE DISEASE; ADULT; ALLOGRAFTS; COLON; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNE TOLERANCE; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INTESTINAL MUCOSA; MALE; MIDDLE AGED; SURVIVAL RATE; UP-REGULATION;

EID: 84908510270     PISSN: 0301472X     EISSN: 18732399     Source Type: Journal    
DOI: 10.1016/j.exphem.2014.04.002     Document Type: Article

References (14)

1. Ferrara J.L., Deeg H.J. Graft-versus-host disease. N Engl J Med 1991, 324:667-674.
2. Mellor A.L., Munn D.H. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol 2004, 4:762-774.
3. Munn D.H., Sharma M.D., Baban B., et al. GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase. Immunity 2005, 22:633-642.
4. Gurtner G.J., Newberry R.D., Schloemann S.R., McDonald K.G., Stenson W.F. Inhibition of indoleamine 2,3-dioxygenase augments trinitrobenzene sulfonic acid colitis in mice. Gastroenterology 2003, 125:1762-1773.
5. Jasperson L.K., Bucher C., Panoskaltsis-Mortari A., et al. Indoleamine 2,3-dioxygenase is a critical regulator of acute graft-versus-host disease lethality. Blood 2008, 111:3257-3265.
6. Steckel N.K., Kuhn U., Beelen D.W., Elmaagacli A.H. Indoleamine 2,3-dioxygenase expression in patients with acute graft-versus-host disease after allogeneic stem cell transplantation and in pregnant women: association with the induction of allogeneic immune tolerance?. Scand J Immunol 2003, 57:185-191.
7. Ratajczak P., Janin A., Peffault de Larour R., et al. IDO in human gut graft-versus-host disease. Biol Blood Marrow Transplant 2012, 18:150-155.
8. Landfried K., Zhu W., Waldhier M.C., et al. Tryptophan catabolism is associated with acute GVHD after human allogeneic stem cell transplantation and indicates activation of indoleamine 2,3-dioxygenase. Blood 2011, 118:6971-6974.
9. Cho B.S., Min C.K., Eom K.S., et al. Feasibility of NIH consensus criteria for chronic graft-versus-host disease. Leukemia 2009, 23:78-84.
10. Lerner K.G., Kao G.F., Storb R., Buckner C.D., Clift R.A., Thomas E.D. Histopathology of graft-vs.-host reaction (GvHR) in human recipients of marrow from HL-A-matched sibling donors. Transplant Proc 1974, 6:367-371.
11. Gooley T.A., Leisenring W., Crowley J., Storer B.E. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 1999, 18:695-706.
12. Ferrara J.L., Levine J.E., Reddy P., Holler E. Graft-versus-host disease. Lancet 2009, 373:1550-1561.
13. Hill G.R., Crawford J.M., Cooke K.R., Brinson Y.S., Pan L., Ferrara J.L. Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines. Blood 1997, 90:3204-3213.
14. Beutelspacher S.C. Expression of indoleamine 2,3-dioxygenase (IDO) by endothelial cells: implications for the control of alloresponses. Am J Transplant 2006, 6:1320-1330.